Description
CJC-1295 Without DAC / Ipamorelin Blend Technical Overview
This research blend combines Modified GRF(1–29), commonly identified commercially as CJC-1295 without DAC, with the synthetic pentapeptide Ipamorelin.
Modified GRF(1–29) is associated with GHRH receptor signaling, while Ipamorelin interacts with the growth hormone secretagogue receptor GHS-R1a.
Although these receptor systems are both associated with endocrine growth hormone regulation, findings concerning individual compounds do not establish the activity of their combination.
Compound Specifications
| Property | Value |
|---|---|
| Product Name | 2X Blend CJC-1295 Without DAC / Ipamorelin |
| Component 1 | Modified GRF(1–29) |
| Component 2 | Ipamorelin |
| Receptor Systems | GHRHR and GHS-R1a |
| DAC Modification | Absent |
| Individual Strengths | Not specified |
| Total Vial Content | Not specified |
Storage and Handling
- Follow manufacturer-provided stability conditions.
- Protect the blend from contamination.
- Use formulation-specific handling practices.
Lyophilized Format
The components may be manufactured in lyophilized form. Combined stability depends on the finished formulation.
Research Use Disclaimer
The blend is not FDA-approved for human therapeutic use and is not intended for human or veterinary administration.
Frequently Asked Questions
What Is This 2X Blend?
A combination of Modified GRF(1–29) and Ipamorelin.
Does It Contain DAC?
No.
Which Receptors Are Involved?
GHRHR and GHS-R1a.
Does 2X Establish Equal Concentrations?
No individual concentrations can be established from the name alone.
Research Overview
The blend is associated with research into complementary endocrine receptor pathways.
GHRHR Research
Modified GRF(1–29) is investigated in GHRH receptor signaling.
GHS-R1a Research
Ipamorelin is studied as a growth hormone secretagogue.
Formulation Research
Combined preparations require studies of stability and compatibility.
Research Applications
| Research Area | In Vitro Application |
|---|---|
| GHRHR | Receptor signaling assays |
| GHS-R1a | Receptor activation studies |
| Peptide Formulation | Compatibility testing |
References
Certificate of Analysis (COA)
Documentation should identify both component sequences, individual amounts, purity, and the blend’s analytical characteristics.
Morana –
Ordered this blend and everything went smoothly. The package arrived well packed, the labels were clear, and communication was easy. Overall, a good experience. I’d order again.